Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Successful treatment for acute heart failure remains elusive

Successful treatment for acute heart failure remains elusive

December 21, 2005

Heart failure experts publish consensus report in Circulation

In recent years, cardiologists have begun to view acute heart failure syndrome (AHFS) as a distinct condition, not merely a part of the chronic heart failure continuum. However, there is not yet a consensus on a definition, epidemiology, appropriate therapy and directions for future research for acute heart failure syndrome, says a Special Report published in today's Circulation journal. The report is the result of the First and Second International Workshops on Acute Heart Failure Syndrome that took place in May 2004 and April 2005.




"Although we've accomplished much in the management of chronic heart failure, the absence of evidence-based clinical practice guidelines for acute heart failure syndrome is striking," says the report's lead author, Mihai Gheorghiade, MD, associate chief, Division of Cardiology at the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital. "I liken the current state of our understanding of acute heart failure to cardiologists understanding of heart attacks before 1980," says Dr. Gheorghiade. "Until then, we thought the clot was the result of the heart attack, not the cause, and so the clot was not being treated. In 2005, we're just at the point of looking for the 'clot' in acute heart failure - what causes it and how can we best treat it?"

Heart failure is the inability of the heart to supply adequate blood flow and therefore oxygen to peripheral tissues and organs and leads to over one million hospitalizations each year in the United States. "We've been successful in finding ways to treat chronic heart failure," says Dr. Gheorghiade. "And, on the surface it looks like we're successful at treating ACHF. Patients are treated, feel better and are discharged. The problem is that within 90 days of discharge, nearly 10 percent of patients die and about 30 percent are readmitted."

Traditionally, cardiologists have treated chronic heart failure and acute heart failure in the same fashion, says Dr. Gheorghiade. "Acute heart failure does not equal chronic heart failure. What's good for one may not be good for the other. For the last two years, every clinical trial with acute heart failure patients has been unsuccessful in improving mortality," says Dr. Gheorghiade

The report calls for a systematic research efforts on the clinical application and translation of promising basic science results and a focus on the choice of appropriate management strategies, including minimizing the use of drugs with adverse effects and development and validation of known prognostic markers to guide AHFS interventions.

The report also states that a significant number of AHFS patients are not being evaluated for potential beneficial surgical procedures that include myocardial revascularization, LV reconstruction, mitral valve surgery, or cardiac transplantation.

The workshops were attended by a selected group of physician scientists, epidemiologists, clinicians, regulatory and government funding agencies, and industry representatives from North and South America and Europe.

Northwestern Memorial Hospital



Related Acute Heart Failure Current Events and Acute Heart Failure News Articles Acute Heart Failure Current Events and Acute Heart Failure News RSS Acute Heart Failure Current Events and Acute Heart Failure News RSS
New mathematical model more accurately diagnoses acute heart failure in emergency rooms
Researchers at St. Michael's Hospital have developed the first mathematical model in cardiology and emergency medicine to more quickly and reliably diagnose acute heart failure (AHF) in emergency room patients.

Mayo Genomic Discovery: Protecting Kidney Function During Heart Failure
Mayo Clinic cardiology researchers have found a peptide that helps preserve and improve kidney function during heart failure, without affecting blood pressure.

Better treatment selection and improved therapies -- key to improving prognosis in acute HF
Today, acute heart failure represents the most common reason for hospitalisation in the over-65 population.

Nitric oxide: Key to cardiovascular and pulmonary function and drug effectiveness
A naturally occurring molecule in the body appears to control whether certain medications, such as beta adrenergic receptor agonists used in acute heart failure or in inhalers for asthma, lose their effectiveness over time.

New study reports improved treatment and reduced mortality for patients with heart failure
UCLA researchers tracked heart failure in-hospital patient trends from 2002 to 2004 for 285 hospitals nationwide and found significant changes in treatment patterns and quality-of-care indicators that paralleled improvements in clinical outcomes and mortality.

First step in developing heart hormone-based pill to control high blood pressure
In an era of increasing death and illness from heart and blood vessel disease — which also can impair kidney function — Mayo Clinic researchers have designed two promising new cardiovascular treatment approaches.

New guidelines issued for diagnosis and management of venous thromboembolism
The American Academy of Family Physicians (AAFP) and American College of Physicians (ACP) today released new clinical practice guidelines for the diagnosis and management of venous thromboembolism (VTE).

Study finds obese patients fair better than lean patients when hospitalized for acute heart failure
Researchers report that for patients hospitalized with acute heart failure, a higher body mass index (BMI) was associated with a substantially lower in-hospital mortality rate.

Systolic blood pressure level for patients with heart failure may help predict risk of death
Patients with heart failure and low systolic blood pressure at hospital admission are more likely to have poor outcomes including higher mortality rates and increased rates of rehospitalization, despite medical treatment.

Heart smart: new drug improves blood flow
A new drug has been shown to improve blood flow in diseased arteries, reducing the risk of high blood pressure and heart attacks.
More Acute Heart Failure Current Events and Acute Heart Failure News Articles
Acute Heart Failure

Acute Heart Failure
by Alexandre Mebazaa (Editor), Mihai Gheorghiade (Editor), Faiez M. Zannad (Editor), Joseph E. Parrillo (Editor)

For many years, there has been a great deal of work done on chronic congestive heart failure while acute heart failure has been considered a difficult to handle and hopeless syndrome. However, in recent years acute heart failure has become a growing area of study. There has been considerable amounts of new data reported and many new concepts have been proposed in the last 3-4 years looking at the epidemiology, diagnostic and treatment of acute heart failure.

Acute Heart Failure: Putting the Puzzle of Pathophysiology and Evidence Together in Daily Practice

Acute Heart Failure: Putting the Puzzle of Pathophysiology and Evidence Together in Daily Practice
by Wolfgang Krüger (Author), Andrew Ludman (Author)

Acute heart failure is a potentially life threatening situation where correct, rapid therapy can have a life saving impact. In this rapidly changing area of medicine this text aims to bring the latest understanding of the pathophysiology together with a practical guide to diagnosis and management using a thoroughly evidence based approach. This will appeal to a wide audience of health care professionals who will treat patients with acute heart failure, including doctors, medical students, nurses, and other professionals in the Emergency Department, General Internal Medicine, Anaesthetics, Cardiology (Medicine and Surgery) and Critical Care settings. It may be used as an evidence based guide for the junior practitioner or as an aide-memoire for the more senior. Always keeping the...

  Campaign to target deficiencies in cardiac care: acute heart failure.(Clinical Rounds): An article from: Family Practice News
by Bruce Jancin (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on January 1, 2004. The length of the article is 1077 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Campaign to target deficiencies in cardiac care: acute heart failure.(Clinical Rounds)
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: January 1, 2004
Publisher: International Medical News Group
Volume: 34 Issue: 1 Page: 21(1)

Distributed by Thomson...

  Is nesiritide safe and effective for acute heart failure?(Pro & Con): An article from: Family Practice News
by Clyde W. Yancy (Author), Jonathan Sackner-Bernstein (Author)

This digital document is an article from Family Practice News, published by Thomson Gale on January 1, 2006. The length of the article is 840 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Is nesiritide safe and effective for acute heart failure?(Pro & Con)
Author: Clyde W. Yancy
Publication: Family Practice News (Magazine/Journal)
Date: January 1, 2006
Publisher: Thomson Gale
Volume: 36 Issue: 1 Page: 10(1)

Distributed by Thomson...

  Natriuretic peptide effective, safe in acute heart failure.(Cardiovascular Medicine): An article from: Internal Medicine News
by Mitchel L. Zoler (Author)

This digital document is an article from Internal Medicine News, published by Thomson Gale on December 1, 2005. The length of the article is 546 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Natriuretic peptide effective, safe in acute heart failure.(Cardiovascular Medicine)
Author: Mitchel L. Zoler
Publication: Internal Medicine News (Magazine/Journal)
Date: December 1, 2005
Publisher: Thomson Gale
Volume: 38 Issue: 23 Page: 38(1)

Distributed by Thomson...

  Levosimendan fails to impress in acute heart failure studies.(Cardiovascular Medicine): An article from: Family Practice News
by Bruce Jancin (Author)

This digital document is an article from Family Practice News, published by Thomson Gale on February 15, 2006. The length of the article is 879 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Levosimendan fails to impress in acute heart failure studies.(Cardiovascular Medicine)
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: February 15, 2006
Publisher: Thomson Gale
Volume: 36 Issue: 4 Page: 18(1)

Distributed by Thomson...

  Acute Heart Failure (Update in Intensive Care and Emergency Medicine)
by C. Perret (Author), J. L. Vincent (Editor)



  Endothelin Antagonist for Acute Heart Failure.(Brief Article): An article from: Family Practice News
by Bruce Jancin (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on June 1, 2001. The length of the article is 505 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Endothelin Antagonist for Acute Heart Failure.(Brief Article)
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: June 1, 2001
Publisher: International Medical News Group
Volume: 31 Issue: 11 Page: 21

Article Type: Brief Article

Distributed by Thomson...

  Obesity paradox deemed irrefutable in patients with acute heart failure.(Cardiovascular Medicine): An article from: Family Practice News
by Bruce Jancin (Author)

This digital document is an article from Family Practice News, published by Thomson Gale on February 15, 2006. The length of the article is 624 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Obesity paradox deemed irrefutable in patients with acute heart failure.(Cardiovascular Medicine)
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: February 15, 2006
Publisher: Thomson Gale
Volume: 36 Issue: 4 Page: 17(1)

Distributed by Thomson...

Management of Acute Decompensated Heart Failure

Management of Acute Decompensated Heart Failure
by Christopher O'Connor (Editor), Wendy Gattis Stough (Editor), Miahai Gheorghiade (Editor), Kirkwood F. Adams (Editor)

Although the majority of heart failure patients represent the exacerbation of chronic disease, about 20% will present as a first time diagnosis. And although there are a number of intravenous agents that can be used for acute decompensated heart failure, there are no national guidelines currently available. Edited by a well-known expert and a carefully selected team of contributors, this book offers evidence-based advice on how they diagnose and treat their patients effectively. The sections cover: epidemiology and pathophysiology, diagnosis and evaluation, comorbidities, treatment strategies, issues in management, and future directions in clinical practice and research.

© 2009 BrightSurf.com